Accessibility Statement Skip Navigation
  • Back to Global Sites
  • +972-77-2005042
  • Blog
  • Journalists
  • GDPR
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +972-77-2005042 from 8 AM - 11 PM IL

    • Contact
    • Contact

      +972-77-2005042
      from 8 AM - 11 PM IL

  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR

FIZE Medical Receives CE Mark and UKCA Certification for Its FIZE kUO® System, Launching Commercial Operations Across Europe and the UK

  • USA - English

News provided by

FIZE Medical

27 Jul, 2026, 16:00 IDT

Share this article

Share toX

Share this article

Share toX

With regulatory clearance in place, FIZE Medical expands its global commercial footprint across Europe and the UK alongside existing operations in North America and Japan

JERICHO, N.Y., July 27, 2026 /PRNewswire/ -- FIZE Medical, a company advancing precision fluid management in critical care, today announced it has received CE mark and UKCA certification for its FIZE kUO® System. This regulatory milestone clears the way for the company to immediately initiate full commercial activities and product distribution across Europe the UK.

The CE Mark and UKCA certification represents another significant milestone in FIZE Medical's global growth strategy. Together with its established commercial presence in North America and Japan, the company is now positioned to expand its reach across the world's major healthcare markets.  

"Receiving the CE Mark and UKCA Certification is a pivotal milestone for FIZE Medical," said Dror Zerem, CEO of FIZE Medical. "It validates the safety, performance, and clinical value of our technology and marks an important step in bringing our solution to hospitals in the EU and the UK. We look forward to partnering with hospitals across Europe and the UK to equip intensive care teams with continuous, real-time digital monitoring that supports precision fluid management, earlier clinical intervention, and better patient outcomes." 

To support its commercial expansion in Europe and the UK, FIZE Medical has established strategic partnerships with leading medical device distributors across key European markets. In parallel, the company has localized its platform for the initial launch countries, providing native-language interfaces that facilitate seamless adoption by healthcare professionals. With its commercial infrastructure now in place, FIZE Medical is ready to begin serving hospitals across Europe and the UK.

For more information about FIZE Medical and its global commercial availability, please visit https://fizemedical.com.

About FIZE Medical

FIZE Medical is a medical technology company dedicated to advancing fluid management in critically ill patients. Its proprietary FIZE kUO system provides real-time, automated monitoring to support precision fluid management, early intervention, and improved patient outcomes. FIZE Medical is committed to redefining fluid management through continuous innovation, AI-driven data insights, and clinical evidence.

Media Contact:
Eran Blankenstein
[email protected] 

SOURCE FIZE Medical

Modal title

Also from this source

FIZE Medical Announces $6 Million Warrant Exercise Bringing Total Series A Financing to $36 Million

FIZE Medical Announces $6 Million Warrant Exercise Bringing Total Series A Financing to $36 Million

FIZE Medical, a medical technology company focused on smart fluid management in critical care, today announced the exercise of stock warrants...

FIZE Medical to Present an Abstract at the 2026 Society of Critical Care Medicine Congress

FIZE Medical to Present an Abstract at the 2026 Society of Critical Care Medicine Congress

FIZE Medical is pleased to share that a clinical research abstract featuring data obtained using the FIZE kUO® platform has been accepted for oral...

More Releases From This Source

Explore

Medical Equipment

Medical Equipment

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

International Medical Approval

International Medical Approval

News Releases in Similar Topics

Contact PR Newswire

  • +972-77-2005042
    from 8 AM - 11 PM IL

Global Sites

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany

 

  • India
  • Indonesia
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland

 

  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Global Sites
  • Asia
  • Brazil
  • Canada
  • Csezh
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italie
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
+972-77-2005042
from 8 AM - 11 PM IL
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2026 Cision US Inc.